Chronic Disease Management Market Poised for Expansion to US$ 14.6 Billion by 2031, Anchored by North America's Advanced ICT Infrastructure | Key Players - TriZetto Corporation, Siemens Healthcare, IBM

Leander Texas -
Chronic Disease Management Market reached US$ 4.8 billion in 2022 and is expected to reach US$ 14.6 billion by 2031, growing with a CAGR of 11.4% during the forecast period 2024-2031.

The market is growing due to rising chronic disease prevalence and increasing digital health adoption in the U.S. and Japan. Recent developments such as the HealthTap-Eli Lilly partnership for virtual diabetes management in the U.S. and expanded digital chronic care platforms are accelerating remote monitoring and integrated care solutions.

Download your executive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/chronic-disease-management-market?prtk

Key Industry Development

United States: Key Industry Developments
✅ December 2025: Omada Health expanded its virtual chronic disease management platform with new AI-powered coaching for diabetes and hypertension, integrating real-time glucose monitoring to boost patient adherence by 25% in high-risk populations.

✅ November 2025: Livongo (Teladoc Health) launched an upgraded connected blood pressure device with predictive analytics for cardiovascular risk, FDA-cleared for remote hypertension management amid rising obesity trends.

✅ October 2025: Medtronic introduced the Guardian Connect 4 system enhancement for continuous glucose monitoring in diabetes care, featuring automated insulin dosing alerts to reduce hypoglycemic events.

Japan: Key Industry Developments
✅ November 2025: Omron Healthcare released the HeartGuide 2.0 wearable for 24/7 blood pressure tracking in hypertension management, approved by PMDA with AI insights for early chronic disease intervention.

✅ September 2025: Fujitsu partnered with local clinics to deploy AI-driven chronic disease care software, focusing on diabetes predictive analytics and IoT remote monitoring for aging patients.

✅ August 2025: Terumo Corporation unveiled a new telehealth-integrated respiratory management device for COPD, incorporating breath analysis sensors to personalize treatment plans under national health subsidies.

Strategic Mergers and Acquisitions

✅ Merck & Co. strengthened its chronic disease therapeutics portfolio by acquiring Verona Pharma in July 2025 in a deal valued at approximately US$ 10 billion. The acquisition provides Merck access to Verona's respiratory drug pipeline, including innovative treatments for chronic obstructive pulmonary disease (COPD), enabling the company to expand its presence in chronic cardiopulmonary disease management and enhance its long-term pharmaceutical growth strategy.

✅ Teladoc Health expanded its digital healthcare ecosystem through the acquisition of Catapult Health in February 2025 for an undisclosed value. The transaction was aimed at strengthening Teladoc's preventive care and at-home diagnostic capabilities, enabling the company to integrate advanced health screening and remote monitoring solutions into its broader chronic disease management platform.

✅ Medtronic enhanced its digital care and remote patient monitoring capabilities by acquiring ChronicCareIQ in May 2025 for an undisclosed amount. The acquisition supports Medtronic's strategy to integrate advanced care management software with its medical device portfolio, allowing healthcare providers to monitor chronic disease patients more effectively and improve long-term patient outcomes.

✅ HEALWELL AI Inc. strengthened its healthcare artificial intelligence capabilities by acquiring the remaining 49% stake in Pentavere Research Group in July 2025. The transaction enabled HEALWELL to gain full ownership of Pentavere's AI-driven patient identification platform, supporting earlier diagnosis and improved clinical decision-making in chronic disease management programs.

Major Players:-
Allscripts Healthcare Solutions Inc. | TriZetto Corporation | Siemens Healthcare Private Limited | IBM | Pegasystems Inc. | Koninklijke Philips NV | EXL Healthcare | Infosys Limited | ScienceSoft USA Corporation | ZeOmega

1. IBM - Market Share: 19.2%
IBM leads the chronic disease management market with about 19.2% market share, driven by its advanced AI-based healthcare analytics and population health management platforms. The company leverages its strong capabilities in big data, predictive analytics, and cloud-based health solutions to help hospitals and payers manage chronic conditions efficiently and improve long-term patient outcomes.

2. Koninklijke Philips NV - Market Share: 16.5%
Koninklijke Philips NV holds approximately 16.5% of the chronic disease management market. The company specializes in integrated population health management and connected care technologies, including remote monitoring and digital health platforms. Its strong hospital partnerships and advanced clinical informatics solutions enable healthcare providers to manage chronic diseases such as cardiovascular disorders and diabetes more effectively.

3. TriZetto Corporation - Market Share: 14.1%
TriZetto Corporation accounts for around 14.1% market share in the chronic disease management market. The company is known for its payer-focused healthcare IT solutions, including care coordination, claims management, and population health platforms. These technologies enable insurers and healthcare providers to streamline chronic disease monitoring, reduce treatment costs, and improve care quality.

4. Allscripts Healthcare Solutions Inc. - Market Share: 12.4%
Allscripts Healthcare Solutions holds nearly 12.4% of the market, supported by its strong electronic health record (EHR) and population health management platforms. Its solutions help healthcare providers track patient data, coordinate care, and monitor chronic diseases continuously, enabling better clinical decision-making and improving long-term patient engagement.

5. Pegasystems Inc. - Market Share: 10.6%
Pegasystems Inc. captures about 10.6% market share, driven by its AI-powered workflow automation and case management platforms. The company's healthcare solutions improve patient engagement, care coordination, and regulatory compliance. Its low-code digital process automation tools allow healthcare organizations to efficiently manage chronic disease treatment programs and operational workflows.

"Secure your 30% discount - get this report before the offer expires."
: https://www.datamintelligence.com/buy-now-page?report=chronic-disease-management-market?prtk (Purchase 2 or more Repots and get 50% Discount)

Market Segmenatation-

By Type (Solutions and Services):
The market is segmented into solutions and services. In the United States, healthcare providers widely adopt integrated chronic disease management solutions such as analytics platforms and remote monitoring tools to manage conditions like diabetes and cardiovascular diseases. In Japan, hospitals increasingly utilize software-based care coordination platforms and implementation services to support the aging population and improve long-term disease management efficiency.

By Disease Type:
Based on disease type, the market includes cardiovascular diseases, diabetes, cancer, asthma, and chronic respiratory diseases. In the U.S., high prevalence of diabetes and cardiovascular diseases drives adoption of digital monitoring and population health management programs. In Japan, the growing elderly population increases demand for management solutions for cardiovascular conditions, diabetes, and respiratory diseases through structured national care programs.

By Deployment Mode:
The deployment segment includes cloud-based, web-based, and on-premises platforms. In the United States, cloud-based chronic disease management systems are widely adopted due to strong health IT infrastructure and integration with electronic health records (EHRs). In Japan, healthcare institutions are gradually shifting toward cloud and hybrid deployment models to support remote patient monitoring and nationwide digital health initiatives.

By Application:
Applications include diabetes management, cardiovascular disease management, respiratory disease management, and cancer management. In the U.S., remote monitoring and telehealth solutions are commonly used to manage diabetes and heart disease. In Japan, digital platforms support continuous monitoring and early intervention programs, particularly for hypertension and cardiovascular conditions prevalent among older adults.

Market Drivers:-

• Rising Burden of Chronic Diseases in the U.S. and Japan: The growing prevalence of long-term illnesses is a major driver for chronic disease management solutions. In the United States, about 6 in 10 adults live with at least one chronic disease and 4 in 10 have two or more, increasing demand for continuous monitoring and coordinated care programs. In Japan, the aging population intensifies this burden, with over 90% of people aged 75+ living with at least one chronic condition, creating strong demand for long-term disease management systems and remote care solutions.

• Rapid Adoption of Remote Patient Monitoring and Telehealth: Healthcare providers in the U.S. are increasingly implementing digital tools for chronic disease care. Nearly 75% of U.S. physicians report using telehealth platforms, and around 90% of healthcare providers have invested in remote patient monitoring technologies, enabling continuous tracking of chronic conditions and reducing hospital readmissions.

• Expansion of Digital Health Infrastructure: Increasing deployment of electronic health records, connected devices, and health data platforms is accelerating chronic disease management adoption. In the U.S., around 85% of office-based physicians utilize electronic health record systems, supporting integrated care coordination, patient monitoring, and analytics-driven treatment for chronic diseases.

• Aging Population Driving Long-Term Care Needs in Japan: Japan's rapidly aging demographic is a major factor increasing demand for chronic disease management solutions. A significant share of older adults suffer from conditions such as diabetes, hypertension, and cardiovascular diseases, encouraging adoption of telemedicine and remote monitoring tools to support continuous care and reduce hospital workload.

• Growing Use of Digital Care Programs and Chronic Care Management (CCM) Initiatives: Government-supported care programs are expanding the use of chronic disease management services. In the United States, over 80,000 physicians enrolled in new Medicare Chronic Care Management programs in 2024, demonstrating increasing institutional focus on proactive monitoring and coordinated long-term care.

Regional insights:-

North America: 44.1% (Largest share, driven by strong healthcare infrastructure and high adoption of digital health platforms for chronic disease monitoring in the United States, where chronic diseases account for a major portion of healthcare spending and care management programs are widely implemented).

Europe: 29.7% (Second-largest share, supported by established healthcare systems, aging populations, and increasing investments in chronic disease management programs across countries such as Germany, the U.K., and France).

Asia Pacific: 18.0% (Rapidly expanding market led by rising chronic disease prevalence and growing digital healthcare adoption in countries such as Japan, China, and India, with Japan alone accounting for about 3.8% of the global market due to its aging population and strong healthcare technology adoption).

Latin America: 5.0% (Emerging adoption of chronic disease management programs, particularly in Brazil and Mexico, supported by expanding healthcare access and gradual digital health integration).

Middle East & Africa: 3.2% (Smallest share due to limited digital healthcare infrastructure, but gradual growth is observed with increasing government initiatives to improve chronic disease monitoring and care delivery).

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/chronic-disease-management-market?prtk

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.